SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-259715
Filing Date
2018-08-28
Accepted
2018-08-28 09:03:00
Documents
3
Period of Report
2018-08-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d609749d8k.htm 8-K 15722
2 EX-99.1 d609749dex991.htm EX-99.1 18845
3 GRAPHIC g609749g0827155117710.jpg GRAPHIC 3108
  Complete submission text file 0001193125-18-259715.txt   40118
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35837 | Film No.: 181040307
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1